What does biopharma laboratory services — goodwill mean?

This represents the intangible asset value recorded when the Biopharma Laboratory Services segment acquires other businesses for a price exceeding the fair market value of their net identifiable assets. It reflects the premium paid for brand reputation, customer relationships, and intellectual property.

Labcorp Holdings LH Biopharma Laboratory Services — Goodwill

Other segment segments

Diagnostics

$5.61B—

Similar metrics at other companies

TMOLaboratory Products and Biopharma Services — Goodwill

$24.23B+1.9%

MLABBiopharmaceutical Development — Goodwill

$49.67M+3.0%

FLGTLaboratory Services — Goodwill

$31.38M—

BDXBioPharma Systems — Goodwill

$96M—

ASHLife Sciences — Goodwill

$462M-42.8%

BLCOPharmaceuticals — Goodwill

$731M+8.0%

Other financials

Income statement

See full

Revenue$3.5B+5.8%

Gross profit$1.0B+6.9%

Operating income$380.8M+16.8%

Net income$277.8M+30.5%

EPS (diluted)$3.35+32.9%

Balance sheet

See full

Cash & equivalents$981.1M+166%

Total debt$7.2B+11.1%

Total equity$8.7B+5.1%

Total assets$19.1B+8.4%

Cash flow

See full

Operating cash flow$191.5M+935%

CapEx$121.0M-4.0%

Free cash flow$70.5M+166%

Valuation

See full

Market cap$22.96B+9.4%

Enterprise value$29.22B+10.7%

P/E24.4×-3.1×

P/S1.6×+0.1×

Profitability

See full

Gross margin28.8%+0.9pp

Operating margin10.2%+1.9pp

Net margin6.7%+1.1pp

FCF margin9.8%+1.0pp

Returns & leverage

See full

Return on equity11.1%+2.1pp

Debt / equity0.8×0.0×

Current ratio1.7×-0.1×

Where this comes from

Reported directly by Labcorp Holdings in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Labcorp Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Labcorp Holdings's biopharma laboratory services — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Labcorp Holdings's biopharma laboratory services — goodwill?: Labcorp Holdings (LH) reported biopharma laboratory services — goodwill of $1.35B in Q1 2026.
What does biopharma laboratory services — goodwill mean?: This represents the intangible asset value recorded when the Biopharma Laboratory Services segment acquires other businesses for a price exceeding the fair market value of their net identifiable assets. It reflects the premium paid for brand reputation, customer relationships, and intellectual property.